Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cell Carcinoma”

15,762 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 15,762 results

Early research (Phase 1)Study completedNCT06469138
What this trial is testing

Investigate 14C-bemcentinib in Healthy Male Subjects

Who this might be right for
Non-Small Cell Lung CancerMetastatic MelanomaAcute Myeloid Leukemia+5 more
BerGenBio ASA 6
Testing effectiveness (Phase 2)WithdrawnNCT03326258
What this trial is testing

Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmEstrogen Receptor NegativeGPNMB Positive+15 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT01470248
What this trial is testing

Study of Arsenic Trioxide in Small Cell Lung Cancer

Who this might be right for
Lung CancerCancer of LungPulmonary Cancer+2 more
Emory University 20
Testing effectiveness (Phase 2)Study completedNCT02089685
What this trial is testing

Safety and Tolerability of Pembrolizumab (MK-3475) + Pegylated Interferon Alfa-2b and Pembrolizumab+ Ipilimumab in Participants With Advanced Melanoma or Renal Cell Carcinoma (MK-3475-029/KEYNOTE-29)

Who this might be right for
Renal Cell CarcinomaMelanoma
Merck Sharp & Dohme LLC 295
Testing effectiveness (Phase 2)Study completedNCT04815720
What this trial is testing

Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)
Vaccinex Inc. 49
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07041788
What this trial is testing

Iparomlimab and Tuvonralimab Combined With SFRT and Definitive Chemoradiotherapy in Locoregionally Advanced Bulky HNSCC

Who this might be right for
Cancer
Second Affiliated Hospital of Nanchang University 25
Not applicableNot Yet RecruitingNCT05752890
What this trial is testing

A Novel Biomarker for Response and Prognosis of HBV-related Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaHepatitis b VirusRadiotherapy+1 more
National Taiwan University Hospital 95
Testing effectiveness (Phase 2)Ended earlyNCT01471197
What this trial is testing

Safety and Efficacy Trial of Ipilimumab Versus Pemetrexed in Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer - Non Small Cell
Bristol-Myers Squibb 9
Not applicableNot Yet RecruitingNCT07542210
What this trial is testing

Barriers and Facilitators of Persistence With Adjuvant Osimertinib

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 100
Not applicableUnknownNCT01838720
What this trial is testing

Zero Ischemia Laparoscopic Radio Frequency Ablation Assisted Enucleation of Renal Cell Carcinoma With T1a Stage

Who this might be right for
Renal Cell CarcinomaZero Ischemia
RenJi Hospital 90
Testing effectiveness (Phase 2)Looking for participantsNCT06636682
What this trial is testing

FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer (Adenocarcinoma)Prostate CAProstate Cancers+4 more
Cellvax Therapeutics Inc 100
Very early researchEnded earlyNCT04906382
What this trial is testing

Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer

Who this might be right for
Lynch SyndromeRecurrent Endometrial CarcinomaRecurrent Endometrial Clear Cell Adenocarcinoma+4 more
Floor Backes, MD 2
Testing effectiveness (Phase 2)Ended earlyNCT02954523
What this trial is testing

Dasatinib and Osimertinib (AZD9291) in Advanced Non-Small Cell Lung Cancer With EGFR Mutations

Who this might be right for
EGFR Gene MutationNonsmall Cell Lung Cancer
Chul Kim 10
Not applicableUnknownNCT01891123
What this trial is testing

Explore the Individual Treatment of Docetaxel and Paclitaxel in NSCLC, NPC and BRC by PK-guided Dosing Strategy

Who this might be right for
Non-small Cell Lung CancerBreast CancerNasal Cancer
Sun Yat-sen University 300
Testing effectiveness (Phase 2)UnknownNCT02036359
What this trial is testing

Erlotinib Monotherapy Versus Docetaxel and Cisplatin as Neoadjuvant Therapy in Patients of stageIIIA Lung ca

Who this might be right for
Non-small Cell Lung Cancer(NSCLC)
National Taiwan University Hospital 76
Testing effectiveness (Phase 2)Study completedNCT01836679
What this trial is testing

Chidamide in Combination With Carboplatin and Paclitaxel in Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small-cell Lung Cancer
Chipscreen Biosciences, Ltd. 124
Testing effectiveness (Phase 2)Study completedNCT00251446
What this trial is testing

A Phase II Single Arm Trial of Single-agent Vinflunine as Second-line Treatment of Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Veeda Oncology 70
Testing effectiveness (Phase 2)Ended earlyNCT05316688
What this trial is testing

A Fluorescent Tumor Marking Agent, Tozuleristide, for Imaging Oral Cavity Squamous Cell Cancer and High-Grade Oral Cavity Dysplasia During Surgery

Who this might be right for
Oral Cavity Squamous Cell CarcinomaStage I Lip and Oral Cavity Cancer AJCC v8Stage II Lip and Oral Cavity Cancer AJCC v8+2 more
University of Washington 8
Not applicableUnknownNCT06120413
What this trial is testing

18F-LN1 PET/CT in Urothelial Carcinomas

Who this might be right for
Urothelial Carcinoma
Sichuan Provincial People's Hospital 30
Very early researchLooking for participantsNCT05060796
What this trial is testing

Study of CXCR5 Modified EGFR Targeted CAR-T Cells for Advanced NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Second Affiliated Hospital of Guangzhou Medical University 11
Load More Results